Search

Michael D. Pak

Examiner (ID: 3628, Phone: (571)272-0879 , Office: P/1646 )

Most Active Art Unit
1646
Art Unit(s)
1674, 1621, 1646, 1812, 0
Total Applications
1549
Issued Applications
718
Pending Applications
268
Abandoned Applications
570

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4710600 [patent_doc_number] => 20080299126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Anti-Myostatin Antibodies' [patent_app_type] => utility [patent_app_number] => 12/066664 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23551 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299126.pdf [firstpage_image] =>[orig_patent_app_number] => 12066664 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/066664
Anti-myostatin antibodies Oct 4, 2006 Issued
Array ( [id] => 6499882 [patent_doc_number] => 20100286229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Modulation of Androgen Receptor for Treatment of Prostate Cancer' [patent_app_type] => utility [patent_app_number] => 11/992874 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 11583 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286229.pdf [firstpage_image] =>[orig_patent_app_number] => 11992874 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/992874
Modulation of Androgen Receptor for Treatment of Prostate Cancer Sep 28, 2006 Abandoned
Array ( [id] => 5323471 [patent_doc_number] => 20090061461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Phosphorylated or Non-Phosphorylated MPR as Diagnostic Marker or Therapeutic Target' [patent_app_type] => utility [patent_app_number] => 11/992699 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13787 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20090061461.pdf [firstpage_image] =>[orig_patent_app_number] => 11992699 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/992699
Phosphorylated or Non-Phosphorylated MPR as Diagnostic Marker or Therapeutic Target Sep 25, 2006 Abandoned
Array ( [id] => 6592762 [patent_doc_number] => 20100130585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'METHODS AND COMPOSITIONS FOR INVESTIGATION AND TREATMENT OF CANCER USING A G-PROTEIN COUPLED EICOSANOID RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/063842 [patent_app_country] => US [patent_app_date] => 2006-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7971 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130585.pdf [firstpage_image] =>[orig_patent_app_number] => 12063842 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/063842
METHODS AND COMPOSITIONS FOR INVESTIGATION AND TREATMENT OF CANCER USING A G-PROTEIN COUPLED EICOSANOID RECEPTOR Aug 27, 2006 Abandoned
Array ( [id] => 4982768 [patent_doc_number] => 20070087326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Method of measuring the biological activity of an urotensin II receptor' [patent_app_type] => utility [patent_app_number] => 11/502774 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6789 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087326.pdf [firstpage_image] =>[orig_patent_app_number] => 11502774 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/502774
Method of measuring the biological activity of an urotensin II receptor Aug 9, 2006 Abandoned
Array ( [id] => 4455582 [patent_doc_number] => 07892826 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Human cell clones having an endogeneous urotensin II receptor' [patent_app_type] => utility [patent_app_number] => 11/501559 [patent_app_country] => US [patent_app_date] => 2006-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6836 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/892/07892826.pdf [firstpage_image] =>[orig_patent_app_number] => 11501559 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/501559
Human cell clones having an endogeneous urotensin II receptor Aug 8, 2006 Issued
Array ( [id] => 6479131 [patent_doc_number] => 20100092464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'M-CSF-Specific Monoclonal Antibody and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/996905 [patent_app_country] => US [patent_app_date] => 2006-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 51409 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092464.pdf [firstpage_image] =>[orig_patent_app_number] => 11996905 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/996905
M-CSF-specific monoclonal antibody and uses thereof Jul 26, 2006 Issued
Array ( [id] => 4530616 [patent_doc_number] => 07887822 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Peptides for stimulating an immune response against melanoma' [patent_app_type] => utility [patent_app_number] => 11/487877 [patent_app_country] => US [patent_app_date] => 2006-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 5909 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/887/07887822.pdf [firstpage_image] =>[orig_patent_app_number] => 11487877 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/487877
Peptides for stimulating an immune response against melanoma Jul 16, 2006 Issued
Array ( [id] => 4612660 [patent_doc_number] => 07989179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'LXR ligand testing method' [patent_app_type] => utility [patent_app_number] => 11/921967 [patent_app_country] => US [patent_app_date] => 2006-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9938 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/989/07989179.pdf [firstpage_image] =>[orig_patent_app_number] => 11921967 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/921967
LXR ligand testing method Jun 25, 2006 Issued
Array ( [id] => 5688918 [patent_doc_number] => 20060287233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells' [patent_app_type] => utility [patent_app_number] => 11/449628 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10973 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287233.pdf [firstpage_image] =>[orig_patent_app_number] => 11449628 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/449628
Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells Jun 8, 2006 Abandoned
Array ( [id] => 1076846 [patent_doc_number] => 07615357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'Ion channel assay methods' [patent_app_type] => utility [patent_app_number] => 11/443721 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 36 [patent_no_of_words] => 44232 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615357.pdf [firstpage_image] =>[orig_patent_app_number] => 11443721 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/443721
Ion channel assay methods May 30, 2006 Issued
Array ( [id] => 216940 [patent_doc_number] => 07611850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'Ion channel assay methods' [patent_app_type] => utility [patent_app_number] => 11/444214 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 54 [patent_no_of_words] => 46898 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/611/07611850.pdf [firstpage_image] =>[orig_patent_app_number] => 11444214 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/444214
Ion channel assay methods May 30, 2006 Issued
Array ( [id] => 5700004 [patent_doc_number] => 20060216688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Ion channel assay methods' [patent_app_type] => utility [patent_app_number] => 11/443697 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 46887 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216688.pdf [firstpage_image] =>[orig_patent_app_number] => 11443697 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/443697
Ion channel assay methods May 30, 2006 Issued
Array ( [id] => 53499 [patent_doc_number] => 07767408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Ion channel assay methods' [patent_app_type] => utility [patent_app_number] => 11/444187 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 36 [patent_no_of_words] => 44184 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767408.pdf [firstpage_image] =>[orig_patent_app_number] => 11444187 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/444187
Ion channel assay methods May 30, 2006 Issued
Array ( [id] => 132317 [patent_doc_number] => 07695922 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Ion channel assay methods' [patent_app_type] => utility [patent_app_number] => 11/443577 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 36 [patent_no_of_words] => 44017 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/695/07695922.pdf [firstpage_image] =>[orig_patent_app_number] => 11443577 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/443577
Ion channel assay methods May 29, 2006 Issued
Array ( [id] => 5689188 [patent_doc_number] => 20060287503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Retinoid X receptor-interacting polypeptides and related molecules and methods' [patent_app_type] => utility [patent_app_number] => 11/443220 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12066 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287503.pdf [firstpage_image] =>[orig_patent_app_number] => 11443220 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/443220
Retinoid X receptor-interacting polypeptides and related molecules and methods May 29, 2006 Abandoned
Array ( [id] => 5888825 [patent_doc_number] => 20060275837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Compositions and methods for assaying hERG channel binding' [patent_app_type] => utility [patent_app_number] => 11/433227 [patent_app_country] => US [patent_app_date] => 2006-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4524 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275837.pdf [firstpage_image] =>[orig_patent_app_number] => 11433227 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/433227
Peptide for assaying hERG channel binding May 10, 2006 Issued
Array ( [id] => 6295226 [patent_doc_number] => 20100160217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'ACETYLYCHOLINE GATED ION CHANNEL CHAPERONS AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 11/919095 [patent_app_country] => US [patent_app_date] => 2006-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11531 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160217.pdf [firstpage_image] =>[orig_patent_app_number] => 11919095 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/919095
ACETYLYCHOLINE GATED ION CHANNEL CHAPERONS AND METHODS OF USING THE SAME May 3, 2006 Abandoned
Array ( [id] => 5422921 [patent_doc_number] => 20090149376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Pharmaceutical and Therapeutic Applications Relating to a Type 9 Adenylyl Cyclase Polymorphism in Asthma and Reversible Bronchial Obstruction' [patent_app_type] => utility [patent_app_number] => 11/912205 [patent_app_country] => US [patent_app_date] => 2006-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6953 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149376.pdf [firstpage_image] =>[orig_patent_app_number] => 11912205 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/912205
Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclase Polymorphism in asthma and reversible bronchial obstruction Apr 23, 2006 Issued
Array ( [id] => 4501828 [patent_doc_number] => 07919584 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-04-05 [patent_title] => 'Methods and compositions for diagnosis and treatment of asthma' [patent_app_type] => utility [patent_app_number] => 11/404458 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36148 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919584.pdf [firstpage_image] =>[orig_patent_app_number] => 11404458 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/404458
Methods and compositions for diagnosis and treatment of asthma Apr 13, 2006 Issued
Menu